The 21 September 2020

A management of patients suffering from Alzheimer's disease at the heart of the Group's concerns

With an estimated of 100 million new patients diagnosed worldwide by 2050, the importance of treating Alzheimer's disease remains a priority for ORPEA Group.


Télécharger le document

The categories

Download the ORPEA corporate presentation